Clapp, Carmen
Diaz-Lezama, Nundehui
Adan-Castro, Elva
Ramirez-Hernandez, Gabriela
Moreno-Carranza, Bibiana
Sarti, Alba Clara
Falzoni, Simonetta
Solini, Anna
Di Virgilio, Francesco http://orcid.org/0000-0003-3566-1362
Funding for this research was provided by:
Consejo Nacional de Ciencia y TecnologĂa (247164)
Associazione Italiana per la Ricerca sul Cancro (IG 13025, IG 18581)
Italian Ministry of Health (RF-2011-02348435)
Article History
Received: 12 January 2019
Accepted: 5 April 2019
First Online: 13 April 2019
Compliance with ethical standards
:
: FDV is a member of the Scientific Advisory Board of Biosceptre Ltd, a UK-based Biotech Company involved in the development of P2X7-targeting antibodies. Other authors declare no conflict of interest.
: Rats were cared for in accordance with the US National Research Council’s Guide for the Care and Use of Laboratory Animals (8th edn, National Academy Press, Washington, DC, USA). The Bioethics Committee of the Institute of Neurobiology of the National University of Mexico (UNAM) approved all animal experiments.
: For this type of study, formal consent is not required.